查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566936

自動免疫檢測設備市場：按產品、應用和最終用戶分類：2024-2033 年全球機會分析和產業預測

Automatic Immunoassay Analyzer Market By Product , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 228 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年，自動免疫檢測設備市值為123億美元，預計2024年至2033年複合年成長率為15.3%，到2033年達到514億美元。

自動免疫檢測設備是利用抗原抗體反應進行免疫檢測，對生物檢體中的蛋白質、荷爾蒙、藥物等物質進行檢測和定量的先進醫療設備。自動化從樣品製備到結果解釋的整個過程，以提高臨床和研究環境中的效率、準確性和通量。它廣泛應用於診斷實驗室、醫院和製藥業，可提供可靠且一致的結果，提高病患照護和檢查結果的速度和品質。

全球自動免疫檢測設備市場的成長主要是由癌症、心血管疾病和糖尿病等慢性疾病盛行率的驚人上升所推動的，這些疾病需要頻繁且準確的診斷測試。根據世界衛生組織 (WHO) 2023 年 9 月發布的一項研究，心血管疾病是最常見的慢性疾病之一，每年導致 1790 萬人死亡，其次是癌症，每年導致約 930 萬人死亡。糖尿病，包括因糖尿病導致的腎臟病死亡。此外，不斷增加的老年人口對市場成長做出了重大貢獻。這是因為，隨著人口老化，對監測和管理與老齡化相關的疾病的診斷測試的需求不斷增加，從而推動了自動免疫檢測設備市場的發展。根據世界衛生組織（WHO）統計，2019年60歲以上人口數達10億。預計到 2030 年，這一數字將增至 14 億，到 2050 年將增至 21 億。隨著老年人口的增加，慢性病的發生率預計將顯著增加。此外，人們對早期疾病檢測和預防性醫療保健重要性的認知不斷提高，導致診斷測試的使用增加，從而推動了對自動免疫檢測設備的需求。個人化醫療的不斷發展趨勢需要準確、及時的診斷訊息，這進一步加速了對可靠、高通量免疫檢測系統的需求。然而，先進的免疫分析儀需要初始投資和維護成本，以及定期維護、校準和技術支持，限制了市場成長。此外，許多國家缺乏足夠的醫療設施來滿足人民的需求，而且准入機會有限也是市場的主要阻礙因素。同時，將免疫檢測分析儀與數位健康平台和電子健康記錄相結合以簡化資料管理並提高實驗室整體工作流程效率的趨勢日益明顯，這將有利於預測期內的市場成長。此外，製造商正致力於開發多重免疫測量，可以從單一樣本同時測量多種生物標記。這些市場開拓預計將為未來幾年的市場成長開闢新的途徑。

自動免疫檢測設備的全球市場分為產品、應用、最終用戶和地區。產品分為螢光、化學冷光、酵素連結螢光系統等。依用途分為感染疾病、內分泌、藥物監測、慢性病、過敏檢測等。依最終用戶分為醫院、診斷實驗室、製藥和生技公司等。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲地區。

主要發現

從產品來看，化學冷光領域預計將在 2024 年至 2033 年期間主導市場。

按申請，2023年感染疾病板塊為大股東。

從最終用戶來看，製藥和生物技術公司領域預計未來幾年自動化免疫檢測設備市場將顯著成長。

從地區來看，自動化免疫檢測設備在不久的將來可能會在北美引起廣泛關注。

該報告可以客製化。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 主要參與者的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章自動免疫檢測設備市場：依產品

  • 市場概況
  • 螢光
  • 化學冷光
  • 酵素連結螢光系統
  • 其他

第5章自動免疫檢測設備市場：依應用分類

  • 市場概況
  • 感染疾病
  • 內分泌學
  • 藥物監測
  • 慢性疾病
  • 過敏測試
  • 其他

第6章 自動免疫學測試設備市場：依最終使用者分類

  • 市場概況
  • 醫院
  • 診斷實驗室
  • 製藥和生物技術公司
  • 其他

第7章自動免疫學測試設備市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國自動化免疫檢測設備市場
    • 加拿大自動免疫檢測設備市場
    • 墨西哥自動免疫檢測設備市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國自動化免疫檢測設備市場
    • 法國自動化免疫檢測設備市場
    • 英國自動免疫檢測設備市場
    • 義大利自動免疫檢測設備市場
    • 西班牙自動免疫檢測設備市場
    • 其他歐洲國家自動免疫檢測設備市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本自動化免疫檢測裝置市場
    • 中國自動化免疫檢測設備市場
    • 印度自動化免疫檢測設備市場
    • 澳洲自動免疫檢測設備市場
    • 韓國自動免疫檢測裝置市場
    • 其他亞太地區自動免疫檢測設備市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西自動免疫檢測設備市場
    • 沙烏地阿拉伯自動免疫檢測設備市場
    • 南非自動免疫檢測設備市場
    • 其他拉丁美洲/中東/非洲自動免疫檢測設備市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Abbott
  • Meril Life Sciences Pvt. Ltd.
  • BioMerieux
  • Arlington Scientific
  • F. Hoffmann-La Roche Ltd
  • Carolina Liquid Chemistries
  • Becton Dickinson And Company,
  • Bio-Rad Laboratories, Inc
  • PerkinElmer Inc.
  • AESKU.GROUP GmbH
簡介目錄
Product Code: A323969

The automatic immunoassay analyzer market was valued at $12.3 billion in 2023, and is projected to reach $51.4 billion by 2033, growing at a CAGR of 15.3% from 2024 to 2033.

Automatic immunoassay analyzer is an advanced medical device that performs immunoassays using antigen-antibody reactions to detect and quantify substances such as proteins, hormones, and drugs in biological samples. By automating the entire process, from sample preparation to result interpretation, these analyzers enhance efficiency, accuracy, and throughput in clinical and research settings. They are widely used in diagnostic laboratories, hospitals, and pharmaceutical industries to provide reliable and consistent results, thereby improving the speed and quality of patient care and research outcomes.

The growth of the global automatic immunoassay analyzer market is majorly driven by alarming rise in prevalence of chronic conditions such as cancer, cardiovascular diseases, and diabetes, which necessitate frequent and accurate diagnostic testing. According to a study published by the World Health Organization in September 2023, cardiovascular diseases are among the most prevalent most chronic diseases, accounting for 17.9 million deaths annually, followed by cancers with about 9.3 million deaths, and diabetes with 2.0 million deaths, including kidney disease deaths caused by diabetes. Furthermore, surge in geriatric population significantly contributes toward the market growth. This is attributed to the fact that as the population ages, there is an increased demand for diagnostic tests to monitor and manage age-related diseases, thereby boosting the market for automatic immunoassay analyzers. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. With increasing aged population, the incidence of chronic conditions is expected to rise significantly. Moreover, rise in awareness about the importance of early disease detection and preventive healthcare is leading to increased use of diagnostic tests, thus driving the demand for automatic immunoassay analyzers. Increase in trend toward personalized medicine, which requires precise and timely diagnostic information, is further accelerating the demand for reliable and high-throughput immunoassay systems. However, high initial investment and maintenance costs of advanced immunoanalyzers and need for regular maintenance, calibration, and technical support restrain the market growth. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, growing trend toward integrating immunoassay analyzers with digital health platforms and electronic health records to streamline data management and improve the overall efficiency of laboratory workflows is expected to offer lucrative opportunities for the market growth during the forecast period. Furthermore, manufacturers are focusing on developing multiplex immunoassays, which allow the simultaneous measurement of multiple biomarkers from a single sample. Such developments are anticipated to open new avenues for the market growth in the coming years.

The global automatic immunoassay analyzer market is segmented into product, application, end user, and region. On the basis of the product, the market is categorized into immunofluorescence, chemiluminescence, enzyme linked fluorescent system, and others. By application, it is classified into infectious diseases, endocrinology, drug monitoring, chronic diseases, allergy testing, and others. Depending on end user, it is divided into hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the chemiluminescence segment is expected to dominate the market from 2024 to 2033.

On the basis of application, the infectious diseases segment was the major shareholder in 2023.

Depending on end user, the pharmaceutical & biotechnology companies segment is poised for significant growth in the automatic immunoassay analyzer market in the coming years.

Region wise, automatic immunoassay analyzers are likely to gain high prominence in North America in the near future.

Competition Analysis

Competitive analysis and profiles of the major players in the global automatic immunoassay analyzer market include Abbott, Meril Life Sciences Pvt. Ltd., BioMerieux, Arlington Scientific, F. Hoffmann-La Roche Ltd, Carolina Liquid Chemistries, Becton Dickinson and Company,, Bio-Rad Laboratories, Inc, PerkinElmer Inc., and AESKU.GROUP GmbH. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Immunofluorescence
  • Chemiluminescence
  • Enzyme Linked Fluorescent System
  • Others

By Application

  • Infectious Diseases
  • Endocrinology
  • Drug Monitoring
  • Chronic Diseases
  • Allergy Testing
  • Others

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Abbott
    • Meril Life Sciences Pvt. Ltd.
    • BioMerieux
    • Arlington Scientific
    • F. Hoffmann-La Roche Ltd
    • Carolina Liquid Chemistries
    • Becton Dickinson and Company,
    • Bio-Rad Laboratories, Inc
    • PerkinElmer Inc.
    • AESKU.GROUP GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Immunofluorescence
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Chemiluminescence
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Enzyme Linked Fluorescent System
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Others
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Infectious Diseases
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Endocrinology
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Drug Monitoring
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Chronic Diseases
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Allergy Testing
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country
  • 5.7. Others
    • 5.7.1. Key Market Trends, Growth Factors and Opportunities
    • 5.7.2. Market Size and Forecast, By Region
    • 5.7.3. Market Share Analysis, By Country

CHAPTER 6: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Diagnostic Laboratories
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Pharmaceutical And Biotechnology Companies
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Others
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Automatic Immunoassay Analyzer Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Automatic Immunoassay Analyzer Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Automatic Immunoassay Analyzer Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Automatic Immunoassay Analyzer Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Automatic Immunoassay Analyzer Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Automatic Immunoassay Analyzer Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Automatic Immunoassay Analyzer Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Automatic Immunoassay Analyzer Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Automatic Immunoassay Analyzer Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Automatic Immunoassay Analyzer Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Automatic Immunoassay Analyzer Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Automatic Immunoassay Analyzer Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Automatic Immunoassay Analyzer Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Automatic Immunoassay Analyzer Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Automatic Immunoassay Analyzer Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Automatic Immunoassay Analyzer Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Automatic Immunoassay Analyzer Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Automatic Immunoassay Analyzer Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Automatic Immunoassay Analyzer Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Meril Life Sciences Pvt. Ltd.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. BioMerieux
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Arlington Scientific
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. F. Hoffmann-La Roche Ltd
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Carolina Liquid Chemistries
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Becton Dickinson And Company,
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Bio-Rad Laboratories, Inc
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. PerkinElmer Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. AESKU.GROUP GmbH
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments